False-positive detection of IgM anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with rheumatoid arthritis: Possible effects of IgM or IgG rheumatoid factors on immunochromatographic assay results

MLA

Shomi Oka, et al. “False-Positive Detection of IgM Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Rheumatoid Arthritis: Possible Effects of IgM or IgG Rheumatoid Factors on Immunochromatographic Assay Results.” SAGE Open Medicine, vol. 10, Mar. 2022. EBSCOhost, https://doi.org/10.1177/20503121221088090.

APA

Shomi Oka, Takashi Higuchi, Hiroshi Furukawa, Kota Shimada, Atsushi Hashimoto, Toshihiro Matsui, & Shigeto Tohma. (2022). False-positive detection of IgM anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with rheumatoid arthritis: Possible effects of IgM or IgG rheumatoid factors on immunochromatographic assay results. SAGE Open Medicine, 10. https://doi.org/10.1177/20503121221088090

Chicago

Shomi Oka, Takashi Higuchi, Hiroshi Furukawa, Kota Shimada, Atsushi Hashimoto, Toshihiro Matsui, and Shigeto Tohma. 2022. “False-Positive Detection of IgM Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Rheumatoid Arthritis: Possible Effects of IgM or IgG Rheumatoid Factors on Immunochromatographic Assay Results.” SAGE Open Medicine 10 (March). doi:10.1177/20503121221088090.